Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Connor SG"" wg kryterium: Autor


Wyświetlanie 1-1 z 1
Tytuł:
Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial.
Autorzy:
Connor SG; Royal Perth Hospital, Perth, Western Australia, Australia.
Fairchild TJ; Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Murdoch, Western Australia, Australia.; Discipline of Exercise Science, Murdoch University, Murdoch, Western Australia, Australia.
Learmonth YC; Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Murdoch, Western Australia, Australia.; Discipline of Exercise Science, Murdoch University, Murdoch, Western Australia, Australia.; Perron Institute of Neurological and Translational Sciences, Nedlands, Western Australia, Australia.
Beer K; Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Murdoch, Western Australia, Australia.; Perron Institute of Neurological and Translational Sciences, Nedlands, Western Australia, Australia.
Cooper I; Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Murdoch, Western Australia, Australia.; Perron Institute of Neurological and Translational Sciences, Nedlands, Western Australia, Australia.
Boardman G; Research Development Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Teo SYM; Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Murdoch, Western Australia, Australia.; Discipline of Exercise Science, Murdoch University, Murdoch, Western Australia, Australia.
Shatahmasseb B; Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Murdoch, Western Australia, Australia.; Discipline of Exercise Science, Murdoch University, Murdoch, Western Australia, Australia.
Zhang R; Department of Clinical Biochemistry, Pharmacology and Toxicology, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, WA, Australia.
Hiscock K; Affinity Clinical Research, Nedlands, Western Australia, Australia.
Coudert JD; Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Murdoch, Western Australia, Australia.; Perron Institute of Neurological and Translational Sciences, Nedlands, Western Australia, Australia.; Division of Medicine, The University of Notre Dame Australia, Fremantle, Western Australia, Australia.
Yeap BB; Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.; Medical School, University of Western Australia, Crawley, Western Australia, Australia.
Needham M; Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Murdoch, Western Australia, Australia.; Perron Institute of Neurological and Translational Sciences, Nedlands, Western Australia, Australia.; Division of Medicine, The University of Notre Dame Australia, Fremantle, Western Australia, Australia.; Department of Neurology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Apr 11; Vol. 18 (4), pp. e0283394. Date of Electronic Publication: 2023 Apr 11 (Print Publication: 2023).
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Testosterone*
Myositis, Inclusion Body*
Male ; Humans ; Aged ; Cross-Over Studies ; Quality of Life ; Pilot Projects ; Exercise ; Muscle Strength/physiology
Czasopismo naukowe
    Wyświetlanie 1-1 z 1

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies